Short answer · Medically reviewed summary · Last updated: 2023-07-13
Schindler disease, also known as Kanzaki disease, is a rare genetic disorder that belongs to a group of conditions called lysosomal storage disorders. It is caused by mutations in the N-acetylglucosamine-1-phosphotransferase (GNPTAB) gene, which is responsible for the production of an enzyme called alpha-N-acetylglucosaminidase. Schindler disease is characterized by the accumulation of certain substances, such as glycolipids and mucopolysaccharides, within the lysosomes of cells throughout the body.
Schindler disease, also known as Kanzaki disease, is a rare genetic disorder that belongs to a group of conditions called lysosomal storage disorders. It is caused by mutations in the N-acetylglucosamine-1-phosphotransferase (GNPTAB) gene, which is responsible for the production of an enzyme called alpha-N-acetylglucosaminidase.
Schindler disease is characterized by the accumulation of certain substances, such as glycolipids and mucopolysaccharides, within the lysosomes of cells throughout the body. This buildup occurs due to the deficiency or malfunction of the alpha-N-acetylglucosaminidase enzyme, leading to impaired lysosomal function.
The symptoms of Schindler disease can vary widely depending on the specific subtype and severity of the condition. There are two main subtypes of Schindler disease: type I and type II.
Type I Schindler disease typically presents in infancy or early childhood. The symptoms may include:
Type II Schindler disease typically presents later in childhood or adolescence. The symptoms may include:
It is important to note that the symptoms and their severity can vary significantly between individuals with Schindler disease, even within the same subtype. Additionally, there may be other less common symptoms associated with the condition.
Diagnosis of Schindler disease involves a combination of clinical evaluation, genetic testing, and assessment of enzyme activity. Treatment options for Schindler disease are currently limited, and management primarily focuses on supportive care to address the specific symptoms and complications experienced by the individual.